Shoskes D A, Cecka J M
Department of Surgery, Harbor-UCLA Medical Center, UCLA School of Medicine, Torrance, California 90502, USA.
Transplantation. 1998 Dec 27;66(12):1697-701. doi: 10.1097/00007890-199812270-00022.
In cadaveric renal transplantation, delayed graft function (DGF) correlates with poor long-term graft survival; however, whether its effects are independent of acute rejection is controversial. We wished to study the effect of DGF on graft survival, controlling for acute rejection, discharge creatinine, and human leukocyte antigen match.
We analyzed 27,096 first cadaveric donor renal transplants reported to the UNOS Scientific Renal Transplant Registry between January 1994 and November 1997. DGF was defined as dialysis need in the first week. Acute rejection was recorded for initial hospitalization and within 6 months. Kaplan Meier survival curves were analyzed with the log rank test.
DGF increased the incidence of acute rejection before discharge (8% without DGF; 25% with DGF, P<0.01) and any acute rejections by 6 months (25% without DGF, 42% with DGF, P<0.01). Without early rejection, DGF reduced 1-year graft survival from 91 to 75% (P<0.0001) and graft half-life from 12.9 to 8.0 years. In kidneys with acute rejection within 6 months, DGF decreased 3-year graft survival from 77 to 60% and graft half-life from 9.4 to 6.2 years (P<0.001). With a discharge creatinine of less than 2.5 mg/dl, the difference in graft half-life between no DGF and no rejection (13.4 years) and DGF with rejection (9.8 years) was significant (P<0.001). Increased donor age and cold ischemia time additionally decreased graft survival, whereas a good human leukocyte antigen match could not overcome the deleterious effects of DGF or acute rejection.
DGF is an important independent predictor of poor graft survival. Newer immunosuppressive strategies must minimize nonimmune and immune renal injury if long-term graft survival is to improve.
在尸体肾移植中,移植肾功能延迟(DGF)与长期移植肾存活不佳相关;然而,其影响是否独立于急性排斥反应仍存在争议。我们希望研究DGF对移植肾存活的影响,并控制急性排斥反应、出院时肌酐水平和人类白细胞抗原匹配情况。
我们分析了1994年1月至1997年11月期间向美国器官共享联合网络(UNOS)科学肾移植登记处报告的27096例首次尸体供肾移植。DGF定义为术后第一周需要透析。记录初次住院期间及6个月内的急性排斥反应情况。采用对数秩检验分析Kaplan-Meier生存曲线。
DGF增加了出院前急性排斥反应的发生率(无DGF者为8%;有DGF者为25%,P<0.01)以及6个月内任何急性排斥反应的发生率(无DGF者为25%,有DGF者为42%,P<0.01)。在无早期排斥反应的情况下,DGF将1年移植肾存活率从91%降至75%(P<0.0001),移植肾半衰期从12.9年降至8.0年。在6个月内发生急性排斥反应的肾脏中,DGF将3年移植肾存活率从77%降至60%,移植肾半衰期从9.4年降至6.2年(P<0.001)。出院时肌酐水平低于2.5mg/dl时,无DGF且无排斥反应组(13.4年)与有DGF且有排斥反应组(9.8年)的移植肾半衰期差异有统计学意义(P<0.001)。供体年龄增加和冷缺血时间延长会进一步降低移植肾存活率,而良好的人类白细胞抗原匹配无法克服DGF或急性排斥反应的有害影响。
DGF是移植肾存活不佳的重要独立预测因素。如果要提高长期移植肾存活率,新的免疫抑制策略必须尽量减少非免疫性和免疫性肾损伤。